Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Kuga

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 10, 2011
[Recent Advances in α-dystroglycanopathy]Atsushi Kuga, Motoi Kanagawa, Tatsushi Toda
Rinsho Shinkeigaku = Clinical Neurology|December 2, 2005
[Posterior spinal cord infarction presenting Brown-Séquard syndrome]Atsushi Kuga, Maki Mitani, Itaru Funakawa, et al.
Rinsho Shinkeigaku = Clinical Neurology|June 26, 2007
[A case of orbital apex syndrome caused by localized invasive aspergillosis successfully treated with voriconazole]Atsushi Kuga, Kenichi Oishi, Haruhiko Ishida, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2004
[Allergic skin rashes by methylprednisolone in a case with multiple sclerosis]Atsushi Kuga, Naonobu Futamura, Itaru Funakawa, et al.
Neuropsychiatric Disease and Treatment|October 14, 2017
Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetineHirofumi Tokuoka, Makoto Nishihara, Shinji Fujikoshi, et al.
Human Molecular Genetics|May 26, 2011
Endoplasmic reticulum stress response in P104L mutant caveolin-3 transgenic miceAtsushi Kuga, Yutaka Ohsawa, Tadashi Okada, et al.
Neuropsychiatric Disease and Treatment|May 2, 2019
Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapyAtsushi Kuga, Tempei Otsubo, Toshinaga Tsuji, et al.
Journal of Affective Disorders|February 29, 2016
Trajectories of depression symptom improvement and associated predictor analysis: An analysis of duloxetine in double-blind placebo-controlled trialsHirofumi Tokuoka, Hitoshi Takahashi, Akichika Ozeki, et al.
Parkinsonism & Related Disorders|August 19, 2007
Characteristics of depression in Parkinson's disease: evaluating with Zung's Self-Rating Depression ScaleFumio Kanda, Kenichi Oishi, Kenji Sekiguchi, et al.
The Journal of Headache and Pain|June 9, 2019
Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programmeKaname Ueda, Wenyu Ye, Louise Lombard, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 10, 2011
[Recent Advances in α-dystroglycanopathy]Atsushi Kuga, Motoi Kanagawa, Tatsushi Toda
Rinsho Shinkeigaku = Clinical Neurology|December 2, 2005
[Posterior spinal cord infarction presenting Brown-Séquard syndrome]Atsushi Kuga, Maki Mitani, Itaru Funakawa, et al.
Rinsho Shinkeigaku = Clinical Neurology|June 26, 2007
[A case of orbital apex syndrome caused by localized invasive aspergillosis successfully treated with voriconazole]Atsushi Kuga, Kenichi Oishi, Haruhiko Ishida, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2004
[Allergic skin rashes by methylprednisolone in a case with multiple sclerosis]Atsushi Kuga, Naonobu Futamura, Itaru Funakawa, et al.
Neuropsychiatric Disease and Treatment|October 14, 2017
Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetineHirofumi Tokuoka, Makoto Nishihara, Shinji Fujikoshi, et al.
Human Molecular Genetics|May 26, 2011
Endoplasmic reticulum stress response in P104L mutant caveolin-3 transgenic miceAtsushi Kuga, Yutaka Ohsawa, Tadashi Okada, et al.
Neuropsychiatric Disease and Treatment|May 2, 2019
Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapyAtsushi Kuga, Tempei Otsubo, Toshinaga Tsuji, et al.
Journal of Affective Disorders|February 29, 2016
Trajectories of depression symptom improvement and associated predictor analysis: An analysis of duloxetine in double-blind placebo-controlled trialsHirofumi Tokuoka, Hitoshi Takahashi, Akichika Ozeki, et al.
Parkinsonism & Related Disorders|August 19, 2007
Characteristics of depression in Parkinson's disease: evaluating with Zung's Self-Rating Depression ScaleFumio Kanda, Kenichi Oishi, Kenji Sekiguchi, et al.
The Journal of Headache and Pain|June 9, 2019
Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programmeKaname Ueda, Wenyu Ye, Louise Lombard, et al.
Pageof 2